News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

OraPharma, Inc. (OPHM) Release: New ARESTIN(R) Website Provides Dental Professionals and Consumers With the Latest Periodontal Disease Information and Resources


5/2/2007 10:39:06 AM

WARMINSTER, PA -- (MARKET WIRE) -- May 02, 2007 -- OraPharma, Inc., a specialty pharmaceutical company specializing in the discovery, development, and commercialization of therapeutics for the treatment of periodontal disease, including ARESTINĀ® (minocycline hydrochloride) Microspheres, 1 mg, recently launched the third generation of its popular web site, www.ARESTIN.com.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES